A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels.
PHASE1
AZD8233 has not been evaluated in clinical studies previously. This is a fi...
To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.
PHASE1
The study is intended to assess the pharmacokinetics (PK), proprotein conve...